Privia Health to Report Third Quarter 2026 Results on Thursday, November 5

Privia Health (Nasdaq: PRVA) will release Q3 2026 financial results on Nov. 5, 2026, before market open, followed by a conference call at 8:00 am ET. The company operates in 25 states, optimizing 1,300+ physician practices and serving 6.1+ million patients.

Original reporting
Published Oct 8, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 1:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PRVA
Neutral
medium confidence
Mentioned
$PRVA
Relevance
4/10
AlphAI data visualization · based on globenewswire.com
Decision brief

The 30-second read

$PRVANeutralLow
01

Why it matters

The scheduled earnings call will set expectations for revenue growth and profitability, influencing analyst forecasts.

02

Market read

The announcement signals an upcoming earnings event that may cause short‑term price movement in PRVA and related health‑tech stocks.

03

What to watch

Potential impact of recent payer contracts or regulatory changes not mentioned in the release.

Relevance 4/10Novelty 3/10Timing: pre-market Thursday Nov 5

Background

Privia Health is a physician‑enablement company operating in 25 states, providing technology and services to medical groups.

Company-level read

Ticker impact

$PRVANeutralMedium confidence
Context

Privia Health announced it will release its Q3 2026 earnings on Thursday, Nov 5 before market open.

Expected impact

potential move as market prices in upcoming earnings

Evidence & confidence

No new financial numbers are disclosed; the article only schedules the release, so impact depends on the results when they arrive.

Market effects

Healthcare services sector may see heightened attention ahead of the earnings season.

U.S. markets may experience modest pre‑market activity in health‑care stocks.

Limited; primarily affects U.S. investors focused on physician‑enablement companies.

Counterpoint

If the market overestimates growth, the earnings could disappoint, prompting a sell‑off.

Key entities

  • Privia Health Group, Inc.

    U.S. physician‑enablement firm (NASDAQ: PRVA).

Related articles

$PRVAHigh

Privia (PRVA) Q3 2026 Earnings Call Transcript

Privia (PRVA) raised its 2026 outlook, expecting 6,000 clinicians by year-end, 23.9% EBITDA growth, and $2.91B in practice collections. It will exit a Montana partnership and acquire American Choice Healthcare for $36M, impacting 2027 metrics. Q3 results showed 12.2% year-over-year provider growth and 21.9% EBITDA increase.

$PRVAHighAI 8/10

Privia Health: Q3 Earnings Snapshot

Privia Health Group Inc. (PRVA) reported Q3 earnings of $13.5M, or 10 cents per share, beating estimates of 9 cents. Revenue was $657M, exceeding forecasts of $599.6M. The company expects full-year revenue between $2.35B and $2.45B.